Publications - iSTAR Medical

Here you can find a list of publications regarding the STAR^® material, the supraciliary space, and MINIject^®.

2024

Dick, Burkhard. “Wirksamkeit und Verträglichkeit eines neuen MIGS-Implantats” (German), DGII aktuell, February 2022.

Fea, Antonio. “Miniject: Harnessing the Drainage Power of the Supraciliary Space”, Glaucoma Today, September / October 2021.
Vold, Steven. “Study: Lower IOP, medication burden in OAG patients“, Ophthalmology Times, July 5 2021.
Hirneiß, Christoph W. “Suprachoroidale Implantate: Aus der Sackgasse auf die Überholspur?” (German), Ophthalmo Chirurgie 33:163-168, May 2021.
García Feijóo, Julián. “Drainage device offers IOP lowering capabilities at 1 year“, Ophthalmology Times, March 15 2021.
Fea, A. “A new route to reducing IOP“, Ophthalmology Times Europe, January 23 2021.

Perzia B, Vold S.D. “Suprachoroidal Devices in Glaucoma Therapy“, Glaucoma Physician, December 1 2020.
Denis P, Hirneiß C, Reddy KP, Kamarthy A, Calvo E, Hussain Z, Ahmed IIK. “Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial”, British Journal of Ophthalmology Published Online First: 03 October 2020. doi: 10.1136/bjophthalmol-2020-316888; in press (Open Access)
García Feijoó J, Denis P, Hirneiß C, Aptel F, Perucho L, Hussain Z, Lorenz K, Pfeiffer N, on behalf of the STAR-II investigators. “A European Study of the Performance and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-II)”, Journal of Glaucoma. 2020 Oct; 29(10):864-871 (Open Access)
Grierson I, Minckler D, Rippy M.K., Marshall A.J., Collignon N, Bianco J, Detry B, Murray J.A. “A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration”, BMC Biomed Eng 2, 10 (2020) (Open Access)

Denis P, Hirneiß C, Reddy KP, Kamarthy A, Calvo E, Hussain Z, Ahmed IIK. “A First-in-Human Study of the Efficacy and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-I)”, Ophthalmology Glaucoma. 2019; 2(5):290-297 (Open Access)
König S, Hirneiß CW. “STARflo-a suprachoroidal drainage implant in glaucoma surgery”, Ophthalmologe. 2018 Aug;115(8):670-675
Fili S, Wölfelschneider P, Kohlhaas M. “The STARflo glaucoma implant: preliminary 12 months results”, Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):773-781
Vinod K. “Suprachoroidal shunts”, Curr Opin Ophthalmol. 2018 Mar;29(2):155-161

Figus M, Posarelli C, Passani A, Albert TG, Oddone F, Sframeli AT, Nardi M. “The supraciliary space as a suitable pathway for glaucoma surgery: Ho-hum or home run?”, Surv Ophthalmol. 2017 Nov – Dec;62(6):828-837
Gigon A, Shaarawy T, “The Suprachoroidal Route in Glaucoma Surgery”, J Curr Glaucoma Pract 2016;10(1):13-20.
Cseke I, Vámosi P, Bausz M, “Starflo glaucoma implant: early experience in Hungary”, Romanian Journal of Ophthalmology, Volume 60, Issue 1, January-March 2016. pp:14-17

Hovanesian J.A, “Three reasons why MIGS in the suprachoroidal space has a bright future”, MedBlog Nov 2015
Kammer J.A, Mundy K.M, “Suprachoroidal Devices in Glaucoma Surgery”, Middle East Afr J Ophthalmol. 2015 Jan-Mar; 22(1): 45–52. doi: 10.4103/0974-9233.148348
Pourjavan S, Collignon N, De Groot V, “STARflo Glaucoma Implant 12 month clinical results”, Acta Ophth, Volume 91, Issue s252, August 2013. DOI: 10.1111/j.1755-3768.2013.3723.x
Fleckman P, UsuiM, Zhao G, et al. “Cutaneous and inflammatory response to long-term percutaneous implants of sphere-templated porous/solid poly(HEMA) and silicone in Mice”, J Biomed Mater Res A. 2012 May; 100(5): 1256–1268. doi:10.1002/jbm.a.34012
“Surgical Innovations in Glaucoma”, Editors: Samples, John R., Ahmed, Iqbal Ike K. (Eds.), Section 22 : STARflo – Pourjavan S, Collignon N.J.M., De Groot V, et al. – Pages 235-251. ISBN 978-1-4614-8348-9